Shu Ze-Liu, Zeng Ke-Wu, Ma Xiao-Li, Tu Peng-Fei, Li Jun, Jiang Yong
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Zhongguo Zhong Yao Za Zhi. 2016 Mar;41(5):922-927. doi: 10.4268/cjcmm20160527.
Baoyuan decoction (BYD) is a classical Chinese formula for coronary heart disease with Qi deficiency, blood stasis tonifying Qi and Yang deficiency. However, the chemical material basis and underlying action mechanisms of BYD still lack systemic study. In order to clarify the active compounds and the potential action mechanisms of BYD, the oxygen-glucose deprivation/recovery (OGD/R)-induced H9c2 cells injury models was used to screen the monomeric compounds of BYD with myocardial protection activity. PubChem's BioAssay database was then used to analyze the potential targets of active monomeric compounds, classify the predicted biological targets, and analyze the internal relation between active compounds of BYD and biological targets. The screening results showed that BYD aqueous extract and 17 monomeric compounds could significantly increase the survival rate of OGD/R-induced H9c2 myocardial cells. The results of virtual targets screening study showed that 15 monomeric compounds and the potential mechanisms for myocardial protection were related to oxidative stress pathway, calcium ion pathway, mitochondrial protection, anti-apoptosis, etc. These results verified that BYD had myocardial protection effect, which was obtained by network regulation of multi-components and multi-targets. All these results provide the theoretical basis and references for the clinical usage of BYD in treatment of coronary heart disease.
保元汤(BYD)是治疗冠心病气虚血瘀、气阳两虚证的经典中药方剂。然而,保元汤的化学物质基础和潜在作用机制仍缺乏系统研究。为阐明保元汤的活性成分及潜在作用机制,采用氧糖剥夺/复氧(OGD/R)诱导的H9c2细胞损伤模型筛选具有心肌保护活性的保元汤单体化合物。随后利用PubChem生物测定数据库分析活性单体化合物的潜在靶点,对预测的生物学靶点进行分类,并分析保元汤活性成分与生物学靶点之间的内在关系。筛选结果表明,保元汤水煎液及17种单体化合物可显著提高OGD/R诱导的H9c2心肌细胞存活率。虚拟靶点筛选研究结果显示,15种单体化合物及其心肌保护的潜在机制与氧化应激途径、钙离子途径、线粒体保护、抗凋亡等有关。这些结果证实保元汤具有心肌保护作用,是通过多成分、多靶点的网络调控实现的。所有这些结果为保元汤治疗冠心病的临床应用提供了理论依据和参考。